be 2254 has been researched along with Adenoma, Prostatic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foglar, R; Hirasawa, A; Horie, K; Shibata, K; Tsujimoto, G | 1 |
1 other study(ies) available for be 2254 and Adenoma, Prostatic
Article | Year |
---|---|
Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Binding, Competitive; Cell Line; Cricetinae; DNA; Humans; Male; Phenethylamines; Plasmids; Prostatic Hyperplasia; Radioligand Assay; Rats; Recombinant Proteins; Tetralones; Transfection | 1995 |